Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Wendy J. Komocsar"'
Autor:
Louise Newton, Jason A. Randall, Theresa Hunter, Shannon Keith, Tara Symonds, Roberta J. Secrest, Wendy J. Komocsar, Sarah E. Curtis, Linda Abetz-Webb, Michael Kappelman, April N. Naegeli
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-13 (2019)
Abstract Background Ulcerative colitis (UC) often first presents during adolescence and early adulthood. Primary symptoms of UC are well known, yet similarities and differences of disease experience in adults and adolescents are not well characterize
Externí odkaz:
https://doaj.org/article/edce99cbb88d4ed2871697ee8cf155ca
Autor:
Kevin L. Winthrop, Clifton O. Bingham, Wendy J. Komocsar, John Bradley, Maher Issa, Rena Klar, Cynthia E. Kartman
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Abstract Background Clinical guidelines recommend pneumococcal and tetanus vaccinations in patients with rheumatoid arthritis (RA). Baricitinib is an oral, selective Janus kinase (JAK) 1/JAK 2 inhibitor and is approved for the treatment of moderately
Externí odkaz:
https://doaj.org/article/fb4179395d57473eb50cfb25ed303174
Autor:
Robert M. Nelson, Laurie S. Conklin, Wendy J. Komocsar, Fei Chen, Forrest Williamson, Wallace V. Crandall
Publikováno v:
Therapeutic Innovation & Regulatory Science. 56:895-902
Master protocols are innovative clinical trial designs that enable new approaches to analytics and operations, creating value for patients and drug developers. To date, the use of master protocols in pediatric drug development has been limited, focus
Autor:
Theresa, Hunter, Wendy J, Komocsar, Richard B, Colletti, Chunyan, Liu, Keith J, Benkov, Jennifer L, Dotson, Steven J, Steiner, Nanhua, Zhang, Wallace, Crandall
Publikováno v:
Current medical research and opinion. 39(1)
To assess treatment patterns and initial and maintenance dosing of biologics over 3 years in pediatric patients with ulcerative colitis (UC) or Crohn's disease (CD), utilizing data from the ImproveCareNow registry.Pediatric patients diagnosed with UC
Autor:
Theresa Hunter, Wendy J Komocsar, Chunyan Liu, Richard B Colletti, Steven J Steiner, Jennifer L Dotson, Keith Benkov, Nanhua Zhang, Wallace Crandall
Publikováno v:
Crohn's & Colitis 360. 4
Background To assess disease activity, steroid-free remission, and other clinical outcome assessments among pediatric patients with ulcerative colitis (UC) and Crohn’s disease (CD) in the ImproveCareNow (ICN) registry. Methods Patients aged 2–17
Autor:
Cynthia E. Kartman, Maher Issa, Wendy J. Komocsar, Clifton O. Bingham, Rena Klar, John S. Bradley, Kevin L. Winthrop
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Clinical guidelines recommend pneumococcal and tetanus vaccinations in patients with rheumatoid arthritis (RA). Baricitinib is an oral, selective Janus kinase (JAK) 1/JAK 2 inhibitor and is approved for the treatment of moderately to sever
Autor:
Jennifer L. Dotson, A Larkin, Tony Hunter, W Crandall, Anthony R. Otley, Wendy J. Komocsar, S Meakin, R Lukanova
Publikováno v:
Journal of Crohn's and Colitis. 15:S202-S203
Background Crohn’s disease (CD) and ulcerative colitis (UC) are chronic gastrointestinal diseases, which often present during one’s most productive years. The objective of this study was to assess the symptomology and most bothersome symptoms of
Autor:
Jennifer L. Dotson, Steven J. Steiner, Keith J. Benkov, Nanhua Zhang, Theresa Hunter, Wendy J. Komocsar, Wallace Crandall, Chunyan Liu, Richard B. Colletti
Publikováno v:
Gastroenterology. 160:S29-S30
Autor:
Chunyan Liu, Richard B. Colletti, Keith J. Benkov, Wallace Crandall, Jennifer L. Dotson, Steven J. Steiner, Nanhua Zhang, Theresa Hunter, Wendy J. Komocsar
Publikováno v:
Gastroenterology. 160:S30
Autor:
Chunyan Liu, Richard B. Colletti, Keith J. Benkov, Wallace Crandall, Jennifer L. Dotson, Nanhua Zhang, Theresa Hunter, Wendy J. Komocsar, Steven J. Steiner
Publikováno v:
Gastroenterology. 160:S17